News
Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater ...
Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...
An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.
7d
Everyday Health on MSNPsoriasis and Rheumatoid Arthritis: Are You at Risk?Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.
DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" highlights the details around ENTYVIO, a gut-selective biologic developed by Takeda Pharmaceutical. The report provides ...
9d
MedPage Today on MSNRegistry Data Reassure on JAK Inhibitors' Heart RisksSuggestions that rheumatoid arthritis (RA) patients suffer more cardiovascular events when treated with Janus kinase (JAK) inhibitors compared with tumor necrosis factor (TNF) blockers or other ...
Transportation Secretary Sean Duffy got into an online exchange with New York’s Metropolitan Transportation Authority (MTA) after an anti-Israel mob took over Grand Central Station. On Monday ...
Abstract: Existing anti-jamming strategies for unmanned aerial vehicle (UAV) networks largely assume homogeneity among UAVs, neglecting the differences in hardware configurations, task requirements, ...
The new whistleblower emails also show that a future member of Special Counsel Jack Smith’s team and an anti-Trump FBI agent were closely involved in the origins of the FBI probe. Operation Arctic ...
Welcoming proposed changes to that effect in parliament on Tuesday (Apr 8), he asked what specific and tailored guidelines will be given to estate agents to accurately identify suspicious ...
New biologic agents have “opened new therapeutic opportunities ... of treatment sequences using intravenous vedolizumab or anti-TNF biologics as first-line therapy in UC and CD, from a Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results